Searle Company plans transfer of biologics portfolio to Nextar, proposes ₨4 billion investment
Home Page - Profit by Pakistan Today [Unofficial]
May 12, 2026
Nextar Pharma to be renamed Searle Biopharma as company seeks shareholder approval for product transfer, trademarks and capital injection
The post Searle Company plans transfer of biologics portfolio to Nextar, proposes ₨4 billion investment appeared first on Profit by Pakistan Today.
Discussion in the ATmosphere